Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06850402
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 25 Years - 49 Years
- Healthy Volunteers
- Not accepted
Interventions
- DeepDOF Images — DEVICEWomen referred for consultation for cervical biopsy(ies) and/or LEEP will be recruited into the experimental group of the study.
Study Details
All patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Sep 1, 2027
- Completion
- Sep 1, 2028
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: DeepDOF ImagesParticipants will be approached by a trained research assistant. After informed consent is obtained, each participant will collect two cervical swabs (self-collected and/or provider-collected) as an optional procedure and stored for future research. VIA and/or colposcopy will be performed per standard of care. Cervical biopsy(ies) and/or LEEP will be performed per standard of care. The specimens will be imaged immediately using DeeDOF at the point of care and then submitted for standard histopathologic analysis as shown in Figure 1.
Primary Outcome Measure
Primary Out Measures [ Time Frame: through study completion, an average of 1 year ]
Central Contacts
- Kathleen M Schmeler, MD(713) 854-9150
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas M. D. Anderson Cancer Center | Houston | Texas | 77030 | Kathleen M Schmeler, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
Related Studies
- FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing SurgeryRecruiting · University Health Network, Toronto · Houston, Texas
- Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix CancerRecruiting · GOG Foundation · Goodyear, Arizona
- A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Bristol-Myers Squibb · Clovis, California